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Edited by Beat ImhofAbstract Expression of nephrin, a crucial component of the glo-
merular slit diaphragm, is downregulated in patients with pro-
teinuric glomerular diseases. Using conditionally immortalized
reporter podocytes, we found that bystander macrophages as well
as macrophage-derived cytokines IL-1b and TNF-a markedly
suppressed activity of the nephrin gene promoter in podocytes.
The cytokine-initiated repression was reversible, observed on both
basal and inducible expression, independent of Wilms’ tumor sup-
pressor WT1, and caused in part via activation of the phosphati-
dylinositol-3-kinase/Akt pathway. These results indicated a novel
mechanism by which activated macrophages participate in the
induction of proteinuria in glomerular diseases.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Proteinuria is a typical clinical feature of glomerular dis-
eases. Under physiologic situations, the glomerular ﬁltration
barrier consisting of the basement membrane and the slit dia-
phragm is maintained by podocytes and regulates passage of
macromolecules in plasma into the urinary space [1]. Recent
investigation identiﬁed nephrin, a podocyte-speciﬁc transmem-
brane protein, as a key regulator for maintaining the structure
and function of the slit diaphragm [2]. Attenuated expression
of nephrin mRNA is often observed in proteinuric glomerular
diseases [3–5], whereas information is very limited regarding
how expression of nephrin is down-regulated under pathologic
circumstances.
Wilms’ tumor suppressor WT1 is constitutively expressed in
podocytes and contributes to basal expression of the nephrinAbbreviations: PKC, protein kinase C; SEAP, secreted alkaline phos-
phatase; FBS, fetal bovine serum; ATRA, all-trans retinoic acid; PI3K,
phosphophatidylinositol-3-kinase; TPA, 12-o-tetradecanoylphorbol-1-
3-acetate; M/CM, macrophage-conditioned medium; LPS, lipopoly-
saccharide; RT-PCR, reverse transcriptase-polymerase chain reaction;
GAPDH, glyceraldehydes-3-phosphate dehydrogenase; REPON, re-
porter podocytes for nephrin; HGF, hepatocyte growth factor; RAR,
retinoic acid receptor; RARE, retinoic acid response element
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doi:10.1016/j.febslet.2006.12.051gene [6,7]. The transacting potential of WT1 is dependent on
its phosphorylation state; i.e., phosphorylation of WT1 by
protein kinase C (PKC) or protein kinase A attenuates its
trans-acting potential [8]. Downregulation of WT1 or its phos-
phorylation may be a possible mechanism for the repression of
nephrin expression. Some reports indicated possible roles of
the nuclear receptor family of molecules on the expression of
nephrin gene. For example, recent reports showed that ago-
nists of peroxisome proliferator-activated receptors upregu-
lated expression of nephrin mRNA [9,10]. We identiﬁed that
nuclear receptor ligands including retinoic acid, vitamin D3
and glucocorticoid upregulate activity of the nephrin gene pro-
moter and nephrin mRNA levels [11]. Although nuclear recep-
tors and their endogenous ligands may contribute to basal
expression of nephrin in podocytes, little is understood about
their involvement in downregulation of nephrin under patho-
logic situations.
Inﬁltration of leukocytes, especially monocytes/macro-
phages, play a decisive role in the development of various pro-
teinuric glomerular diseases [12]. Under pathologic conditions,
activated macrophages secrete various inﬂammatory media-
tors and stimulate resident cells toward functional alteration.
Depletion of macrophages or inhibition of macrophage inﬁl-
tration attenuates glomerular injury and proteinuria, suggest-
ing a critical role of macrophages in the development of
proteinuria [13,14]. Recently, we found that podocytes exposed
to macrophages exhibited down-regulation of nephrin mRNA.
We hypothesized that, under pathologic situations, inﬁltrating
local macrophages may repress nephrin expression, leading to
proteinuria. The purpose of the present study is to investigate
whether macrophages can suppress activity of the nephrin gene
promoter in podocytes, and if so, how macrophage-derived
factors regulate expression of the nephrin gene.2. Materials and methods
2.1. Cells
Reporter podocytes REPON5.4 were established by stable transfec-
tion of murine podocytes with pN5.4-SEAP that introduces the
secreted alkaline phosphatase (SEAP) gene under the control of the
5.4 kb murine nephrin gene promoter [11]. To prepare pN5.4-SEAP,
the 5.4 kb promoter fragment was excised from p5.4N-nlacF (kindly
provided by Dr. Lawrence B. Holzman, University of Michigan Med-
ical School) [15] by digestion with KpnI and NcoI. After blunting the
NcoI site, those fragments were subcloned into multiple cloning sitesblished by Elsevier B.V. All rights reserved.
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CA). As a control, murine podocytes were stably transfected with
pSEAP2-Control (Clontech) that introduces the SEAP gene under
the control of the simian virus 40 promoter [11]. Murine macrophage
J774.1 cells were obtained from Riken Bioresource Center (Ibaraki,
Japan) and used for co-culture and cross-feeding studies, as described
later.2.2. Pharmacological treatment
Reporter podocytes were seeded onto collagen-coated plates, pre-
incubated for 48 h in RPMI-1640 containing 10% fetal bovine serum
(FBS) and exposed to test reagents as follows; IL-1b (human recombi-
nant, 0.02–200 ng/ml; Genzyme, Cambridge, MA), TNF-a (human
recombinant, 0.1–100 ng/ml; Genzyme), 1,25-dihydroxyvitamin D3
(100 nM; Chugai Pharmaceutical Co. Ltd., Tokyo, Japan), all-trans
retinoic acid (ATRA, 1 lM; Genzyme), phosphophatidylinositol-3-ki-
nase (PI3K) inhibitor LY294002 (50 lM; Sigma–Aldrich Japan,
Tokyo), PKC inhibitor calphostin C (40 nM; Sigma–Aldrich) and
12-o-tetradecanoylphorbol-13-acetate (TPA, 50 nM; Sigma–Aldrich).
Macrophage-conditioned medium (M/CM) was prepared using
J774.1 cells as described previously [16]. All assays were performed
in the presence of 1% FBS.2.3. Co-culture
J774.1 cells were activated with lipopolysaccharide (LPS, 1 lg/ml;
Sigma–Aldrich) for 6 h. After washing twice, the macrophages
(1 · 104 cells/well) were seeded onto conﬂuent cultures of reporter
podocytes (1 · 104 cells/well) in 96-well plates. After 24 h, culture med-
ia were subjected to SEAP assay, as described later.
2.4. Reverse transcriptase-polymerase chain reaction (RT-PCR)
RT-PCR analysis of nephrin gene expression was performed using
Omniscript Reverse Transcriptase (Qiagen, Tokyo, Japan), as de-
scribed before [11]. Expression of glyceraldehydes-3-phosphate dehy-
drogenase (GAPDH) was used as a loading control.Fig. 1. Repression of the nephrin gene promoter in podocytes by bystand
producing SEAP under the control of the simian virus 40 promoter (ri
lipopolysaccharide (LPS; 1 lg/ml) for 24 h, and culture media were subjecte
treated for 24 h with conditioned media from activated J774.1 macrophages
assay (B, left) and formazan assay (B, right). Activity of SEAP was normaliz
(C). Data are expressed as means ± S.E., and asterisks indicate statistically s2.5. Northern blot analysis
Total RNA was extracted by a single-step method, and Northern
blot analysis was performed as described previously [16]. Murine
WT1 cDNA (kindly provided by Dr. Holger Scholz, Charite-Univers-
itatsmedizen, Berlin) [17] was used to prepare a radio-labeled probe.
Expression of GAPDH was used as a loading control.
2.6. Western blot analysis
Phosphorylation of Akt was evaluated by Western blot analysis [18]
using anti-phospho-Akt Ab (1/200 dilution; Santa Cruz Biotechnology,
Santa Cruz, CA). As a loading control, identical ﬁlters were re-probed
for b-actin using anti-b-actin Ab (1/30000 dilution; Sigma–Aldrich).
2.7. Chemiluminescent assay
Activity of SEAP was evaluated by a chemiluminescent method
using Great EscAPe SEAP detection kit (BD Bioscience, Palo Alto,
CA) [19].
2.8. Formazan assay
The number of viable cells was assessed by a formazan assay using
Cell Counting Kit-8 (Dojindo Laboratory, Kumamoto, Japan) [11].
2.9. Statistical analysis
Assays were performed in quadruplicate. Data are expressed as
means ± S.E. Statistical analysis was performed using the non-paramet-
ric Mann–Whitney U test to compare data in diﬀerent groups. P value
<0.05 was considered to indicate a statistically signiﬁcant diﬀerence.3. Results
3.1. Repression of the nephrin gene promoter in podocytes by
bystander macrophages
In glomerular diseases, activated macrophages play crucial
roles in the induction of proteinuria. We hypothesized thater macrophages. (A) Reporter podocytes REPON (left) or podocytes
ght) were co-cultured with J774.1 macrophage pre-stimulated with
d to secreted alkaline phosphatase (SEAP) assay. (B,C) REPON were
(M/CM; 0–50 %), and culture media and cell were subjected to SEAP
ed by the number of viable cells, and the resultant values are shown in
igniﬁcant diﬀerences (P < 0.05).
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expression, via direct contact or via elaborating inﬂammatory
mediators. To examine these possibilities, we used murine re-
porter podocytes for nephrin (REPON) that secrete SEAP
under the control of the murine nephrin gene promoter [11].
As the ﬁrst step of investigation, REPON were co-cultured
for 24 h with pre-activated murine macrophages J774.1, and
culture media were subjected to chemiluminescent assay to
evaluate SEAP activity. As shown in Fig. 1A (left), activity
of the nephrin gene promoter in podocytes was signiﬁcantly re-
duced to 37.8 ± 5.3% by bystander macrophages. In contrast,
when control podocytes constitutively expressing SEAP under
the control of a viral promoter were co-cultured with macro-
phages, the activity of SEAP was not declined (Fig. 1A, right).
This result conﬁrmed that the macrophage-triggered reduction
of SEAP in the reporter cells was not due to cellular damage.
To identify mechanisms involved in the eﬀect of macrophages,
cross-feeding studies were performed. REPON were exposed
to serial concentrations of M/CM derived from J774.1 cells,
and activity of SEAP was evaluated. The result showed that
M/CM signiﬁcantly repressed activity of the nephrin gene
promoter (Fig. 1B, left). Even in the presence of 5% M/CM,
activity of the promoter was reduced to 37.2 ± 6.4%. In con-
trast, the number of viable cells was signiﬁcantly increased
by M/CM in a dose-dependent manner (Fig. 1B, right). Nor-
malization of SEAP activity by the number of viable cells
revealed dose-dependent suppression of the nephrin promoter
by M/CM (Fig. 1C).Fig. 2. Repression of basal nephrin promoter activity by inﬂammatory cyto
200 ng/ml; left) or TNF-a (0–100 ng/ml; right), and culture media and cells we
Reporter podocytes were exposed to IL-1b (20 ng/ml; left) or TNF-a (10 ng
subjected to SEAP assay. (D) Cells were pretreated for 24 h with IL-1b or T
SEAP produced during initial 24 h and next 24 h was evaluated by chemilu
(P < 0.05). N.S, not statistically signiﬁcant.3.2. Repression of basal nephrin promoter activity in podocytes
by inﬂammatory cytokines
Activated macrophages produce IL-1b and TNF-a abun-
dantly [16,18], and these cytokines are involved in the patho-
genesis of glomerular diseases [20]. We tested eﬀects of IL-1b
and TNF-a on the activity of the nephrin gene promoter in
REPON. As shown in Fig. 2A, these cytokines repressed activ-
ity of the nephrin gene promoter in a dose-dependent manner.
To exclude a possibility that the downregulation of SEAP by
these cytokines might be caused by nonspeciﬁc damage of
the reporter podocytes, the cells used for chemiluminescent
assay were subsequently subjected to formazan assay to evalu-
ate the number of viable cells. At any concentrations tested,
cell viability was unaﬀected by IL-1b or TNF-a (Fig. 2B).
Time-lapse experiments revealed that signiﬁcant suppression
of the nephrin gene promoter was observed within 8–12 h
(Fig. 2C). The suppressive eﬀects of IL-1b and TNF-a on
the nephrin expression were further conﬁrmed by RT-PCR.
Consistent with the results shown in Fig. 2A, the basal level
of nephrin mRNA was depressed by these cytokines (Supple-
mental Fig. 1).
To examine whether or not the repression of nephrin by
cytokines was reversible, REPON were pretreated with IL-1b
or TNF-a for 24 h and then incubated without cytokines for
up to 48 h. During the initial 24 h after the treatment (0–
24 h), suppression of SEAP was still observed (Fig. 2D, left).
However, subsequent incubation for additional 24 h (24–
48 h) did not show signiﬁcant inhibition of SEAP activity inkines. (A,B) Reporter podocytes were treated for 24 h with IL-1b (0–
re subject to SEAP assay (A) and formazan assay (B), respectively. (C)
/ml; right) for up to 12 h, and culture media sampled every 4 h were
NF-a and then incubated without cytokines for up to 48 h. Activity of
minescent assay. Asterisks indicate statistically signiﬁcant diﬀerences
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that the suppression of the nephrin gene promoter by cyto-
kines is reversible.
3.3. Repression of inducible nephrin promoter activity in
podocytes by inﬂammatory cytokines
We recently reported that 1,25-dihydroxyvitamin D3 and
ATRA upregulated activity of the nephrin gene promoter
and nephrin mRNA levels in podocytes [11]. We next exam-
ined whether activation of the nephrin promoter by 1,25-
dihydroxyvitamin D3 or ATRA is also inhibited by inﬂamma-
tory cytokines. REPON were treated with IL-1b or TNF-a in
the presence of 1,25-dihydroxyvitamin D3 or ATRA, and cul-
ture media were subjected to chemiluminescent assay. As
shown in Fig. 3A, activation of the nephrin gene promoter
by 1,25-dihydroxyvitamin D3 was signiﬁcantly attenuated by
IL-1b or TNF-a. Similarly, activation of the nephrin gene pro-
moter by ATRA was abrogated by the treatment with these
cytokines (Fig. 3B). Consistently, induced expression of neph-
rin mRNA was downregulated by cytokines modestly in 1,25-
dihydroxyvitamin D3-treated cells (Fig. 3C, upper) and
markedly in ATRA-treated cells (Fig. 3C, lower).
3.4. Molecular mechanisms involved in transcriptional
suppression of nephrin by cytokines
Previous reports showed that WT1 is a crucial transcription
factor that upregulates expression of nephrin in podocytes [6,7]
and that the transacting potential is attenuated due to its phos-
phorylation by, for example, PKC [8]. Phosphorylation of
WT1 by inﬂammatory cytokines may cause suppression of
the nephrin promoter. Indeed, treatment of REPON with
TPA, an activator of PKC, signiﬁcantly suppressed the level
of SEAP (Fig. 4A). However, treatment with calphostin C,
an inhibitor of PKC, did not aﬀect suppression of the nephrin
promoter by IL-1b or TNF-a (Fig. 4B). Furthermore, North-
ern blot analysis revealed that treatment of the cells with IL-1b
or TNF-a did not suppress but rather enhanced expression of
WT1 mRNA (Fig. 4C). These results indicated lack of involve-Fig. 3. Repression of inducible nephrin promoter activity by inﬂammatory
TNF-a (10 ng/ml) in the absence () or presence (+) of 1,25-dihydroxyvitam
1 lM) (B,C) for 24 h, and culture media and cells were subject to SEAP assa
nephrin and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) (C). A
reaction without reverse transcriptase.ment of WT1 in the suppression of nephrin expression by
inﬂammatory cytokines.
Recently, we found that hepatocyte growth factor (HGF), a
putative de-diﬀerentiation factor of podocytes [21], markedly
suppressed activity of the nephrin gene promoter (Supplemen-
tal Fig. 2A) as well as expression of nephrin mRNA (Supple-
mental Fig. 2B). HGF is a well-known activator of PI3K/
Akt in various cells, including REPON (Supplemental
Fig. 2C), and activation of PI3K/Akt by IL-1b and TNF-a is
observed in some cell types [22,23]. We speculated that the
PI3K/Akt pathway might be involved in the suppression of
the nephrin gene in podocytes. Indeed, Western blot analysis
revealed that phosphorylation of Akt was rapidly induced in
podocytes after the treatment with IL-1b or TNF-a
(Fig. 4D). Of note, IL-1b activated Akt to less extent and
for shorter term than TNF-a. Interestingly, treatment with
LY294002, a PI3K inhibitor, abrogated the suppressive eﬀect
of TNF-a, but not IL-1b (Fig. 4E). These results indicated dif-
ferential involvement of the PI3K/Akt pathway in the suppres-
sion of nephrin gene expression by macrophage-derived,
proinﬂammatory cytokines.4. Discussion
In this report, we describe that bystander macrophages have
the ability to suppress expression of nephrin in podocytes via
production of inﬂammatory cytokines. The cytokine-initiated
repression of nephrin was reversible, observed on both basal
and inducible expression, and independent of Wilms’ tumor
suppressor WT1. In contrast to our present ﬁndings, a previous
report indicated that, in A293 human embryonic kidney cells
and primary culture of human podocytes, IL-1b and TNF-a
upregulated nephrin gene expression [24]. The reason for the
discrepancy is currently unclear, but regulation of nephrin in
human podocytes could be diﬀerent from that in murine podo-
cytes, or diﬀerent culture conditions such as serum concentra-
tions might have aﬀected the experimental outcome.cytokines. Reporter podocytes were treated with IL-1b (20 ng/ml) or
in D3 [1,25(OH)2D3; 100 nM] (A,C) or all-trans retinoic acid (ATRA;
y (A,B) and reverse transcriptase-polymerase chain reaction analysis of
sterisks indicate statistically signiﬁcant diﬀerences (P < 0.05). RT(),
Fig. 4. Molecular mechanisms involved in transcriptional suppression of nephrin by cytokines. (A) Reporter podocytes were treated with 12-o-
tetradecanoylphorbol-13-acetate (TPA, 50 nM) for 24 h, and culture media were subjected to SEAP assay. (B) Cells were pretreated with calphostin
C (40 nM) for 30 min and subsequently exposed to IL-1b (20 ng/ml) or TNF-a (10 ng/ml). Culture media were subject to SEAP assay. (C) Reporter
podocytes were stimulated with IL-1b or TNF-a for 24 h, and expression of WT1 was examined by Northern blot analysis. Expression of GAPDH is
shown at the bottom as a loading control. (D) Reporter podocytes were treated with IL-1b or TNF-a for indicated time periods, and levels of
phosphorylated Akt (p-Akt) and total Akt were examined by Western blot analysis. (E) Reporter podocytes were pretreated with or without
LY294002 (50 lM) for 30 min, subsequently exposed to IL-1b or TNF-a, and subject to SEAP assay. Asterisks indicate statistically signiﬁcant
diﬀerences (P < 0.05). N.S, not statistically signiﬁcant.
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responsible for the suppressive eﬀect of TNF-a. Currently,
downstream events involved in the suppressive eﬀect of PI3K/
Akt are unclear. The fact that substantial expression of nephrin
in podocytes requiredATRA (Fig. 3) raises a possibility that the
PI3K/Akt pathwaymay aﬀect signal transduction pathways ini-
tiated by ATRA. ATRA is an active metabolite of vitamin A
and a ligand of the nuclear receptor, retinoic acid receptor
(RAR). After binding of ATRA to RAR, RAR forms homodi-
mers or heterodimers with retinoid X receptor, and the resultant
complexes exert biological eﬀects via binding to the particular
cis element, the retinoic acid response element (RARE). Func-
tional RAREs are present in the regulatory region of the human
nephrin gene [25], and ATRA can induce expression of nephrin
through activation of these regulatory elements. Recently, Srin-
ivas et al. report that Akt inhibited retinoid-induced transacti-
vation in lung cancer cells via phosphorylation at the Ser96
residue of the RARa’s DNA-binding domain [26]. Mutation
of Ser96 to alanine abrogated the suppressive eﬀect of Akt,
and overexpression of a dominant-negative mutant of Akt de-
creased RAR phosphorylation and increased RAR transactiva-
tion. Lefebvre et al. also reported that the PI3K/Akt pathway
aﬀected recruitment of some co-repressor to the RARb2 pro-
moter, leading to down-regulation of RARb2 expression and
impairment of cellular responses to ATRA [27]. These results
suggest that activation of the PI3K/Akt pathway by TNF-a
suppressed the function of RARs, impaired the retinoid signal-
ing, and thereby downregulated nephrin expression. In the pres-
ent study, however, we found that down-regulation of nephrinby IL-1b was independent of the PI3K/Akt pathway. Although
IL-1b caused phosphorylation of Akt, inhibition of PI3K did
not signiﬁcantly aﬀect the suppressive eﬀect of this cytokine
on nephrin expression. It might be due to the fact that IL-1b
activated Akt to less extent and for shorter term than TNF-a,
as shown in this report (Fig. 4D).
Inﬁltration of macrophages plays a crucial role in the devel-
opment of various proteinuric glomerular diseases [12]. Acti-
vated macrophages produce inﬂammatory cytokines
abundantly, which is involved in the development of protein-
uria in glomerular diseases [28]. In anti-glomerular basement
membrane antibody glomerulonephritis (a model of Goodpas-
ture syndrome in human), activated podocytes contribute to the
formation of cellular crescents where inﬁltrating macrophages
are co-localized [29]. In this experimental model, (1) proteinuria
is caused by inﬁltration ofmacrophages [30], (2) activated podo-
cytes undergo phenotypic changes and lose expression of neph-
rin [29], and (3) proteinuria and crescent formation are
ameliorated either by administration with IL-1 receptor antag-
onist or by gene knockout of TNF-a [31,32]. Based on these
data together with our current ﬁndings, we propose a novel
mechanism involved in the induction of proteinuria in macro-
phage-associated, proteinuric glomerular diseases. Under path-
ologic situations, inﬁltrating glomerular macrophages produce
proinﬂammatory cytokines and thereby repress expression of
nephrin in podocytes, leading to development of proteinuria.Acknowledgements: We thank Dr. Holger Scholz (Charite-Universi-
tatsmedizen, Berlin) for providing us with a WT1 cDNA, Dr. Karlhans
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